Evaluation of the Impact of Psychological Profile on Diabetic Foot Wound Healing. Prospective, Monocentric Study
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DIJON · Oct 4, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring how a person's psychological profile might affect the healing of foot wounds in patients with type 2 diabetes. Researchers want to understand if individuals with a "Type A" personality—who tend to be more competitive and stressed—heal differently than those with a "Type B" personality, who are generally more relaxed and less combative. The study will include 308 patients with type 2 diabetes who have a new foot wound, all being treated at the Dijon Bourgogne University Hospital.
To participate, individuals must be over 18 years old, have type 2 diabetes, and be referred for treatment of a foot wound. Those who are pregnant, unable to consent, or under legal protections won't be included. Participants will complete a self-questionnaire to assess their psychological profile and will be monitored for how their wounds heal over time. This trial is important because it could help doctors understand how personality traits influence healing and possibly reduce the risk of severe complications, like amputation, for diabetic patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Person who has given his non-opposition
- • Person over 18 years of age
- • Person with type 2 diabetes
- • Person referred for management of a new diabetic foot wound
- Exclusion Criteria:
- • Person subject to a legal protection measure (curatorship, guardianship)
- • Person subject to a legal protection measure
- • Pregnant women, women in labour or breastfeeding mothers
- • An adult who is incapable or unable to give consent
- • Minors
- • Person unable to complete self-questionnaires
About Centre Hospitalier Universitaire Dijon
The Centre Hospitalier Universitaire Dijon (CHU Dijon) is a leading academic medical institution in France, dedicated to advancing healthcare through innovative research and clinical trials. With a focus on patient-centered care, CHU Dijon integrates comprehensive medical services with cutting-edge research initiatives across various specialties. The institution is committed to enhancing clinical outcomes and improving health standards by facilitating rigorous scientific investigations and collaborations with national and international partners. By prioritizing ethical practices and adherence to regulatory standards, CHU Dijon aims to contribute significantly to the development of new therapies and medical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dijon, Bourgogne, France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported